Literature DB >> 19177349

Conformational changes within the HLA-A1:MAGE-A1 complex induced by binding of a recombinant antibody fragment with TCR-like specificity.

Pravin Kumar1, Ardeschir Vahedi-Faridi, Wolfram Saenger, Andreas Ziegler, Barbara Uchanska-Ziegler.   

Abstract

Although there is X-ray crystallographic evidence that the interaction between major histocompatibility complex (MHC, in humans HLA) class I molecules and T cell receptors (TCR) or killer cell Ig-like receptors (KIR) may be accompanied by considerable changes in the conformation of selected residues or even entire loops within TCR or KIR, conformational changes between receptor-bound and -unbound MHC class I molecules of comparable magnitude have not been observed so far. We have previously determined the structure of the MHC class I molecule HLA-A1 bound to a melanoma antigen-encoding gene (MAGE)-A1-derived peptide in complex with a recombinant antibody fragment with TCR-like specificity, Fab-Hyb3. Here, we compare the X-ray structure of HLA-A1:MAGE-A1 with that complexed with Fab-Hyb3 to gain insight into structural changes of the MHC molecule that might be induced by the interaction with the antibody fragment. Apart from the expulsion of several water molecules from the interface, Fab-Hyb3 binding results in major rearrangements (up to 5.5 A) of heavy chain residues Arg65, Gln72, Arg145, and Lys146. Residue 65 is frequently and residues 72 and 146 are occasionally involved in TCR binding-induced conformational changes, as revealed by a comparison with MHC class I structures in TCR-liganded and -unliganded forms. On the other hand, residue 145 is subject to a reorientation following engagement of HLA-Cw4 and KIR2DL1. Therefore, conformational changes within the HLA-A1:MAGE-A1:Fab-Hyb3 complex include MHC residues that are also involved in reorientations in complexes with natural ligands, pointing to their central importance for the peptide-dependent recognition of MHC molecules.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19177349      PMCID: PMC2708021          DOI: 10.1002/pro.4

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  62 in total

1.  A T cell receptor CDR3beta loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex.

Authors:  Jean Baptiste Reiser; Claude Grégoire; Claudine Darnault; Thomas Mosser; Annick Guimezanes; Anne Marie Schmitt-Verhulst; Juan Carlos Fontecilla-Camps; Gilbert Mazza; Bernard Malissen; Dominique Housset
Journal:  Immunity       Date:  2002-03       Impact factor: 31.745

2.  The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization.

Authors:  Lars Kjer-Nielsen; Craig S Clements; Andrew G Brooks; Anthony W Purcell; Marcos R Fontes; James McCluskey; Jamie Rossjohn
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

3.  A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity.

Authors:  Lars Kjer-Nielsen; Craig S Clements; Anthony W Purcell; Andrew G Brooks; James C Whisstock; Scott R Burrows; James McCluskey; Jamie Rossjohn
Journal:  Immunity       Date:  2003-01       Impact factor: 31.745

4.  Grasping molecular structures through publication-integrated 3D models.

Authors:  Pravin Kumar; Alexander Ziegler; Julian Ziegler; Barbara Uchanska-Ziegler; Andreas Ziegler
Journal:  Trends Biochem Sci       Date:  2008-07-30       Impact factor: 13.807

5.  Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen.

Authors:  K C Garcia; M Degano; L R Pease; M Huang; P A Peterson; L Teyton; I A Wilson
Journal:  Science       Date:  1998-02-20       Impact factor: 47.728

6.  T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide.

Authors:  Fleur E Tynan; Scott R Burrows; Ashley M Buckle; Craig S Clements; Natalie A Borg; John J Miles; Travis Beddoe; James C Whisstock; Matthew C Wilce; Sharon L Silins; Jacqueline M Burrows; Lars Kjer-Nielsen; Lyudmila Kostenko; Anthony W Purcell; James McCluskey; Jamie Rossjohn
Journal:  Nat Immunol       Date:  2005-09-25       Impact factor: 25.606

7.  HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.

Authors:  D N Garboczi; D T Hung; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

8.  A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3.

Authors:  Martin Hülsmeyer; Patrick Chames; Roman C Hillig; Robyn L Stanfield; Gerhard Held; Pierre G Coulie; Claudia Alings; Gabriele Wille; Wolfram Saenger; Barbara Uchanska-Ziegler; Hennie R Hoogenboom; Andreas Ziegler
Journal:  J Biol Chem       Date:  2004-11-10       Impact factor: 5.157

9.  A correlation between TCR Valpha docking on MHC and CD8 dependence: implications for T cell selection.

Authors:  Jennifer Buslepp; Huanchen Wang; William E Biddison; Ettore Appella; Edward J Collins
Journal:  Immunity       Date:  2003-10       Impact factor: 31.745

10.  A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody.

Authors:  S Eastman; M Deftos; P C DeRoos; D H Hsu; L Teyton; N S Braunstein; C J Hackett; A Rudensky
Journal:  Eur J Immunol       Date:  1996-02       Impact factor: 5.532

View more
  10 in total

1.  Loss of recognition by cross-reactive T cells and its relation to a C-terminus-induced conformational reorientation of an HLA-B*2705-bound peptide.

Authors:  Bernhard Loll; Christine Rückert; Chee Seng Hee; Wolfram Saenger; Barbara Uchanska-Ziegler; Andreas Ziegler
Journal:  Protein Sci       Date:  2010-12-23       Impact factor: 6.725

2.  Prediction of peptide binding to a major histocompatibility complex class I molecule based on docking simulation.

Authors:  Takeshi Ishikawa
Journal:  J Comput Aided Mol Des       Date:  2016-09-13       Impact factor: 3.686

3.  Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA.

Authors:  Christopher J Holland; Rory M Crean; Johanne M Pentier; Ben de Wet; Angharad Lloyd; Velupillai Srikannathasan; Nikolai Lissin; Katy A Lloyd; Thomas H Blicher; Paul J Conroy; Miriam Hock; Robert J Pengelly; Thomas E Spinner; Brian Cameron; Elizabeth A Potter; Anitha Jeyanthan; Peter E Molloy; Malkit Sami; Milos Aleksic; Nathaniel Liddy; Ross A Robinson; Stephen Harper; Marco Lepore; Chris R Pudney; Marc W van der Kamp; Pierre J Rizkallah; Bent K Jakobsen; Annelise Vuidepot; David K Cole
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

4.  NMR spectroscopy reveals unexpected structural variation at the protein-protein interface in MHC class I molecules.

Authors:  Monika Beerbaum; Martin Ballaschk; Natalja Erdmann; Christina Schnick; Anne Diehl; Barbara Uchanska-Ziegler; Andreas Ziegler; Peter Schmieder
Journal:  J Biomol NMR       Date:  2013-09-05       Impact factor: 2.835

5.  Crystal structure of swine major histocompatibility complex class I SLA-1 0401 and identification of 2009 pandemic swine-origin influenza A H1N1 virus cytotoxic T lymphocyte epitope peptides.

Authors:  Nianzhi Zhang; Jianxun Qi; Sijia Feng; Feng Gao; Jun Liu; Xiaocheng Pan; Rong Chen; Qirun Li; Zhaosan Chen; Xiaoying Li; Chun Xia; George F Gao
Journal:  J Virol       Date:  2011-09-07       Impact factor: 5.103

6.  Structural basis for T cell alloreactivity among three HLA-B14 and HLA-B27 antigens.

Authors:  Pravin Kumar; Ardeschir Vahedi-Faridi; Wolfram Saenger; Elena Merino; José A López de Castro; Barbara Uchanska-Ziegler; Andreas Ziegler
Journal:  J Biol Chem       Date:  2009-07-18       Impact factor: 5.157

7.  A novel T cell receptor single-chain signaling complex mediates antigen-specific T cell activity and tumor control.

Authors:  Jennifer D Stone; Daniel T Harris; Carolina M Soto; Adam S Chervin; David H Aggen; Edward J Roy; David M Kranz
Journal:  Cancer Immunol Immunother       Date:  2014-08-01       Impact factor: 6.968

8.  Activity of 8F4, a T-cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivo.

Authors:  A Sergeeva; H He; K Ruisaard; L St John; G Alatrash; K Clise-Dwyer; D Li; R Patenia; R Hong; P Sukhumalchandra; M J You; M Gagea; Q Ma; J J Molldrem
Journal:  Leukemia       Date:  2016-03-08       Impact factor: 11.528

Review 9.  Opportunities and Challenges for Antibodies against Intracellular Antigens.

Authors:  Xiaofeng Yang; Shenxia Xie; Xiaomei Yang; Juan C Cueva; Xiaoqiong Hou; Zhuoran Tang; Hua Yao; Fengzhen Mo; Shihua Yin; Aiqun Liu; Xiaoling Lu
Journal:  Theranostics       Date:  2019-10-15       Impact factor: 11.556

Review 10.  Three-Dimensional Portable Document Format (3D PDF) in Clinical Communication and Biomedical Sciences: Systematic Review of Applications, Tools, and Protocols.

Authors:  Axel Newe; Linda Becker
Journal:  JMIR Med Inform       Date:  2018-08-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.